Breaking News, Collaborations & Alliances

AbbVie, Immunome Enter Antibody Alliance

Multi-year collaboration aims to identify up to 10 novel target-antibody pairs using Immunome's Discovery Engine.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AbbVie and Immunome, Inc., a clinical-stage biopharmaceutical company that utilizes its human memory B cell platform to develop first-in-class antibody therapeutics, have entered a worldwide collaboration and option agreement to discover up to 10 novel antibody-target pairs arising from three specified tumor types using Immunome’s Discovery Engine.   Immunome will grant AbbVie the option to purchase worldwide rights for up to 10 novel target-antibody pairs arising from the selected tumor...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters